Načítá se...
Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway
BACKGROUND: CD300A, a type I transmembrane glycoprotein receptor, plays an important role in immune response. Recent studies have reported that CD300A is involved in the development of hematological malignancies. PURPOSE: The objective of this study was to investigate the role of CD300A in the progr...
Uloženo v:
| Vydáno v: | Onco Targets Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6290927/ https://ncbi.nlm.nih.gov/pubmed/30573974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S185521 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|